Background: The management of hydrocephalus secondary to intraventricular haemorrhage in neonates can be controversial. Temporary diversion of cerebrospinal fluid (CSF) is often required due to the low birth weight and high risks of shunting in these patients. Ventriculosubgaleal (VSG) CSF diversion is an effective way of achieving this goal whilst minimising the risks of complications. It is a well-described technique but is rarely used in contemporary neurosurgical practice. Methods: Nine neonates treated with VSG shunting for post-haemorrhagic hydrocephalus were assessed. Gestational age, birth weight, duration of treatment efficacy, requirement for permanent shunting and complications were recorded. Results: In all 9 patients, the VSG shunt controlled the progression of hydrocephalus. A permanent shunt was avoided in 2 patients. One patient required revision of the subgaleal shunt to extend the interval to the insertion of a permanent shunt. None of the patients developed any CSF infection or leak. Conclusion: VSG CSF diversion offers a simple, effective and relatively safe means of treating hydrocephalus in the neonate, with a low risk of complications and the possibility of avoiding permanent shunting.

Willis BK, Kumar CR, Wylen EL, Nanda A: Ventriculosubgaleal shunt for posthemorrhagic hydrocephalus in premature infants. Pediatr Neurosurg 2005;41;178–185.
Reinprecht A, Dietrich W, Berger A, Bavinzski G, Weninger M, Czech T: Posthemorrhagic hydrocephalus in preterm infants: long-term follow-up and shunt-related complications. Childs Nerv Syst 2001;17:663–669.
Aschoff A, Kremer P, Hashemi B, Kunze S: The scientific history of hydrocephalus and its treatment. Neurosurg Rev 1999;22:67–93.
Tubbs RS, Smyth MD, Wellons JC, Blount JP, Grabb PA, Oakes WJ: Life expectancy of ventriculosubgaleal shunt revisions. Pediatr Neurosurg 2003;38:244–246.
Benzel EC, Reeves JP, Nguyen PK, Hadden TA: The treatment of hydrocephalus in preterm infants with intraventricular haemorrhage. Acta Neurochir (Wein) 1993;122:200–203.
Cramer BC, Walsh EA: Cisterna magna clot and subsequent post-hemorrhagic hydrocephalus. Pediatr Radiol 2001;3:153–159.
International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group. Lancet 1998;352:433–440.
Garton HJ, Piatt JH Jr: Hydrocephalus. Pediatr Clin North Am 2004;51:305–325.
Gower DJ, Baker Al, Bell WO, Ball MR: Contraindication to lumbar puncture as defined by computed cranial tomography. J Neurol Neurosurg Psychiatry 1987;50:1071–1074.
Gurtner P, Bass T, Gudeman SK, Penix JO, Philput CB, Schinco FB: Surgical management of posthemorrhagic hydrocephalus in 22 low-birth-weight infants. Childs Nerv Syst 1992;8:198–202.
Rhodes TT, Edward WH, Saunders RL, Harbaugh RE, Little CL, Morgan LJ, Sargent SK: External ventricular drainage for initial treatment of neonatal posthemorrhagic hydrocephalus: surgical and neurodevelopmental outcome. Pediatr Neurosci 1987;13:255–262.
Cornips E, Van Calenbergh F, Piets C, Devlieger H, Casaer P: Use of external ventricular drain for posthemorrhagic hydrocephalus in very low birth weight premature infants. Childs Nerv Syst 1997;13:369–374.
Hudgins RJ, Boydston WR, Gilreath CL: Treatment of posthaemorrhagic hydrocephalus in the preterm infants with a ventricular access device. Pediatr Neurosurg 1998;29:309–313.
Richard E, Cinalli G, Assis D, Pierre-Kahn A, Lacaze-Masmonteil T: Treatment of post-haemorrhage ventricular dilatation with an Ommaya’s reservoir: management and outcome of 64 preterm infants. Childs Nerv Syst 2001;17:334–340.
Tenbrock K, Kribs A, Roth B, Spender B: Hyponatraemia as a consequence of serial liquor punctures in preterm infants with a ventricular access device after posthaemorrhagic hydrocephalus. Arch Dis Child Fetal Neonatal Ed 2003;88:F351.
Heep A, Engelskirchen R, Holschneider A, Groneck P: Primary intervention for posthemorrhagic hydrocephalus in very low birthweight infants by ventriculostomy. Childs Nerv Syst 2001;17:47–51.
Gaskill SJ, Marlin AE, Rivera S: The subcutaneous ventricular reservoir: an effective treatment of posthaemorrhagic hydrocephalus. Childs Nerv Syst 1988;4:291–295.
Tubbs RS, Smyth MD, Wellons JC, Blount JP, Grabb PA, Oakes WJ: Alternative uses for the subgaleal shunt in pediatric neurosurgery. Pediatr Neurosurg 2003;39:22–24.
Tubbs RS, Banks JT, Soleau S, Smyth MD, Wellons JC, Blount JP, Grabb PA, Oakes J: Complications of ventriculosubgaleal shunts in infants and children. Childs Nerv Syst 2005,21:48–51.
Fulmer BB, Grabb PA, Oakes WJ, Mapstone TB: Neonatal ventriculosubgaleal shunts. Neurosurgery 2000;47:80–83, discussion 83–84.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.